NCT05292443 2024-02-23Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver CancerGeneplus-Beijing Co. Ltd.Withdrawn
NCT00759109 2017-04-07Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)Merck Sharp & Dohme LLCPhase 3 Completed150 enrolled 12 charts